1Kuler LH, Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in MRFIT tested case-control study. Am J Epidemiol, 1996, 144:537~547
2Haverkate F, Thampson SG, Pyke SDM, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet, 1997, 349:462~466
3Linnanmaki E, Leinonen M, Mattile K, et al. Chlamydia pnenmoniae-specific circu lating immune complexes in patients with chronic coronary heart lisease. Circulation, 1993, 87:1130~1134
4Marrow DA, Ritai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol, 1998, 31:1460~1465
5Ueda S, Ikeda U, Yamamoto K, et al. C-reactive protein as a predictor of cardiac rapture after acute myocardial infarction. Am Heart J, 1996, 131:875~960
6Gaspardone A, Crea F, Versaci F, et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol, 1998, 82:515~518
7Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation, 2001, 104:992~997
8Celik S, Baykan M, Erdol C, et al. C-reactive protein as a risk tactor for left Ventricular throntus in patients with acute myocardial infarction. Clin Cardiol, 2000, 24:615~619
9Pasceri V, Willerson JT, Yeh ET. Direct prointlammatory effect of C-reactive protein on human endothelial cells.Circulation, 2000,102:2165~2168
10Puleo PR, Meyer D, Wathen C, et al. Use of rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med, 1994, 331:556~561